Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression

Sex and Genetic Factors Determine Osteoblastic Differentiation Potential of Murine Bone Marrow Stromal Cells

(2014) Stefano Zanotti et al.   PLoS One

Perlecan is required for FGF-2 signaling in the neural stem cell niche

(2014) Aurelien Kerever et al.   Stem Cell Research

PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells

(2013) Qing-hua Zhao et al.   FEBS Journal

Synovial perlecan is required for osteophyte formation in knee osteoarthritis

(2013) Haruka Kaneko et al.   MATRIX BIOLOGY

Acute Genome-Wide Effects of Rosiglitazone on PPARγ Transcriptional Networks in Adipocytes

(2013) Anders Kristian Haakonsson et al.   MOLECULAR ENDOCRINOLOGY

Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation

(2012) Muneaki Ishijima et al.   MATRIX BIOLOGY

Isolation and Characterization of Multipotential Mesenchymal Cells from the Mouse Synovium

(2012) Ippei Futami et al.   PLoS One

Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition

(2010) Zhuo Xu et al.   MATRIX BIOLOGY

The influence of sex on the chondrogenic potential of muscle-derived stem cells: Implications for cartilage regeneration and repair

(2008) Tomoyuki Matsumoto et al.   ARTHRITIS AND RHEUMATISM

Diverse Cell Signaling Events Modulated by Perlecan†

(2008) John M. Whitelock et al.   BIOCHEMISTRY